Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2244.95-2.7 (-0.12 %)
PREV CLOSE () 2247.65
OPEN PRICE () 2060.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 39732
TODAY'S LOW / HIGH ()2060.35 2251.30
52 WK LOW / HIGH ()2014.85 2726.75
NSE2245.50-2.1 (-0.09 %)
PREV CLOSE() 2247.60
OPEN PRICE () 2161.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2245.50 (70)
VOLUME 545017
TODAY'S LOW / HIGH() 2161.00 2251.10
52 WK LOW / HIGH ()2012.3 2716.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1991

Management Info :

Ramesh Juneja - Chairman Rajeev Juneja - Managing Director

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone : 011-46846700 / 47476600

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
27Feb Clarification sought from Mankind Pha
The Exchange has sought clarification from Mankind Pharma Ltd on Februar..
03Feb Mankind Pharm reports 8% rise in Q3 co
Mankind Pharma has reported results for third quarter ended December 31,..
13Nov Mankind Pharma submits analyst meet in
Pursuant to Regulation 30 read with Part A of Schedule III of the Securi..
07Nov Mankind Pharma reports 21% fall in Q2
Mankind Pharma has reported result for second quarter ended September 30..
29Oct Mankind Pharma informs about earnings
Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit4494.719454.8
Gross Profit 5052.9 23059.9
Operating Profit 8347.730557.6
Net Sales 26326.894978
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26827.45 (1.25%)
M.Cap ( in Cr)
57006.46
Neuland Laboratories (BSE)
 13095.80 (2.26%)
M.Cap ( in Cr)
16801.77
NGL Fine-Chem (BSE)
 2405.50 (4.90%)
M.Cap ( in Cr)
1486.12
Procter&Gamble Healt (BSE)
 4987.90 (1.56%)
M.Cap ( in Cr)
8279.61
Torrent Pharma (BSE)
 4371.05 (0.77%)
M.Cap ( in Cr)
147936.19
Shareholding Pattern
PROMOTERS 72.66%
MUTUAL FUNDS/UTI 9.3%
NON-INSTITUTION 2.79%
FI/BANKS/INSURANCE 1.12%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX80238.85-1048.34 (-1.29%)
NIFTY24865.70-312.95 (-1.24%)
Dow Jones 48904.78-73.14 (-0.15%)
Nasdaq 22748.8680.65 (0.36%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI